|
 |
|
Class Information
Number: 530/402
Name: Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof > Proteins, i.e., more than 100 amino acid residues > Chemical modification or the reaction product thereof, e.g., covalent attachment or coupling, etc.
Description: Subject matter under 350 including a step of chemically modifying a protein or the product of such modification.
Sub-classes under this class:
Patents under this class:
Patent Number |
Title Of Patent |
Date Issued |
8709755 |
Mirac proteins |
Apr. 29, 2014 |
8703921 |
Compositions and methods for delivering inhibitory oligonucleotides |
Apr. 22, 2014 |
8703914 |
Heterologous expression of neisserial proteins |
Apr. 22, 2014 |
8703722 |
Inhibitors of F18+ E coli binding |
Apr. 22, 2014 |
8703427 |
Biological materials and uses thereof |
Apr. 22, 2014 |
8686122 |
Molecular conjugate |
Apr. 1, 2014 |
8686115 |
Compositions and methods for quantitatively monitoring lipids |
Apr. 1, 2014 |
8680249 |
Leafthopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
Mar. 25, 2014 |
8674064 |
Immunogenic compositions against human progastrin peptides |
Mar. 18, 2014 |
8652474 |
Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof |
Feb. 18, 2014 |
8642744 |
Crosslinking reagent for analysis of protein-protein interaction |
Feb. 4, 2014 |
8642743 |
Method for reducing the immune response to a biologically active protein |
Feb. 4, 2014 |
8633300 |
Selective reduction and derivatization of engineered proteins comprising at least one non-native cysteine |
Jan. 21, 2014 |
8629109 |
Method for promoting bone growth using activin-actriia antagonists |
Jan. 14, 2014 |
8628593 |
Process to separate lipids from lipid-containing biomass for producing platform chemicals and/or liquid biofuels |
Jan. 14, 2014 |
8623324 |
Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates |
Jan. 7, 2014 |
8618266 |
Hasylated polypeptides |
Dec. 31, 2013 |
8618265 |
Haptens, hapten conjugates, compositions thereof and method for their preparation and use |
Dec. 31, 2013 |
8614302 |
Modified carbocyanine dyes and their conjugates |
Dec. 24, 2013 |
8614182 |
GLP-1 analogues and their pharmaceutical salts and uses |
Dec. 24, 2013 |
8609815 |
Methods for preparing stable deoxygenated PEG-hemoglobin conjugate solutions comprising an antioxidant |
Dec. 17, 2013 |
8609613 |
Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides |
Dec. 17, 2013 |
8604127 |
Conjugate of catechol-modified polyethylene glycol with protein or peptide and preparation method thereof |
Dec. 10, 2013 |
8603483 |
Anti-integrin immunoconjugates, methods and uses |
Dec. 10, 2013 |
8598324 |
Anti-pathogen treatments |
Dec. 3, 2013 |
8586711 |
Polymer-factor IX moiety conjugates |
Nov. 19, 2013 |
8586710 |
Process for gram scale production of PEG-r-metHuG-CSF |
Nov. 19, 2013 |
8586532 |
Method for selectively modifying a protein via transglutaminase catalyzed reaction |
Nov. 19, 2013 |
8580932 |
Method of thermostabilization of a protein and/or stabilization towards organic solvents |
Nov. 12, 2013 |
8580811 |
Androgen receptor modulator methods |
Nov. 12, 2013 |
8569481 |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
Oct. 29, 2013 |
8569463 |
Method of covalently modifying proteins with organic molecules to prevent aggregation |
Oct. 29, 2013 |
8569454 |
YS68 polypeptide involved in primitive hematopoiesis |
Oct. 29, 2013 |
8569043 |
Detection of post-translationally modified peptides with liquid crystals |
Oct. 29, 2013 |
8568728 |
Beta-glucuronide-linker drug conjugates |
Oct. 29, 2013 |
8568727 |
Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them |
Oct. 29, 2013 |
8563519 |
Methods of activating or inhibiting G protein coupled receptors (GPCRs) |
Oct. 22, 2013 |
8563513 |
Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use |
Oct. 22, 2013 |
8557601 |
Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides |
Oct. 15, 2013 |
8552159 |
Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy |
Oct. 8, 2013 |
8546547 |
Polymer conjugates of Box-A of HMGB1 and Box-A variants of HMGB1 |
Oct. 1, 2013 |
8546535 |
Lytic domain fusion constructs and methods of making and using same |
Oct. 1, 2013 |
8546531 |
Methods and reagents for preparing multifunctional probes |
Oct. 1, 2013 |
8546328 |
Liquid formulation of G-CSF conjugate |
Oct. 1, 2013 |
8541564 |
Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof |
Sep. 24, 2013 |
8540977 |
IL-11 muteins |
Sep. 24, 2013 |
8536314 |
Fluorescent proteins, their production and use |
Sep. 17, 2013 |
8530417 |
Y-shaped polyethylene glycol modified G-CSF, the preparation and use thereof |
Sep. 10, 2013 |
8530212 |
Carbene precursor compound for producing an adhesive surface on a substrate |
Sep. 10, 2013 |
8524244 |
Targeted therapeutics based on engineered proteins that bind EGFR |
Sep. 3, 2013 |
|
|
|